Louisiana State Employees Retirement System Reduces Position in Certara, Inc. (NASDAQ:CERT)

Louisiana State Employees Retirement System cut its position in shares of Certara, Inc. (NASDAQ:CERT) by 2.4% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 52,900 shares of the company’s stock after selling 1,300 shares during the period. Louisiana State Employees Retirement System’s holdings in Certara were worth $619,000 at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. Blue Trust Inc. purchased a new position in shares of Certara during the 2nd quarter worth about $26,000. Innealta Capital LLC bought a new stake in Certara during the 2nd quarter valued at about $36,000. Intech Investment Management LLC bought a new stake in Certara during the 2nd quarter valued at about $152,000. Algert Global LLC bought a new stake in Certara during the 2nd quarter valued at about $156,000. Finally, MQS Management LLC bought a new stake in Certara during the 2nd quarter valued at about $162,000. 73.96% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

CERT has been the subject of a number of research analyst reports. JMP Securities reiterated a “market perform” rating on shares of Certara in a report on Wednesday, July 10th. Robert W. Baird decreased their price objective on shares of Certara from $18.00 to $13.00 and set a “neutral” rating for the company in a report on Tuesday. Barclays decreased their price objective on shares of Certara from $16.00 to $14.00 and set an “equal weight” rating for the company in a report on Tuesday, October 15th. UBS Group upgraded shares of Certara from a “neutral” rating to a “buy” rating and set a $16.00 price objective for the company in a report on Friday, September 27th. Finally, KeyCorp reduced their price target on shares of Certara from $23.00 to $20.00 and set an “overweight” rating for the company in a report on Thursday, July 11th. Six analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat, Certara currently has an average rating of “Hold” and a consensus price target of $16.25.

Insider Transactions at Certara

In other news, insider Patrick F. Smith sold 5,409 shares of Certara stock in a transaction that occurred on Monday, October 7th. The shares were sold at an average price of $11.03, for a total value of $59,661.27. Following the transaction, the insider now owns 50,091 shares of the company’s stock, valued at $552,503.73. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In other news, insider Leif E. Pedersen sold 51,224 shares of Certara stock in a transaction that occurred on Monday, September 9th. The shares were sold at an average price of $11.29, for a total value of $578,318.96. Following the transaction, the insider now owns 99,704 shares of the company’s stock, valued at $1,125,658.16. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Patrick F. Smith sold 5,409 shares of Certara stock in a transaction that occurred on Monday, October 7th. The stock was sold at an average price of $11.03, for a total transaction of $59,661.27. Following the completion of the transaction, the insider now directly owns 50,091 shares in the company, valued at approximately $552,503.73. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders own 2.39% of the company’s stock.

Certara Trading Up 0.6 %

NASDAQ:CERT opened at $10.31 on Wednesday. Certara, Inc. has a one year low of $9.99 and a one year high of $19.87. The company has a debt-to-equity ratio of 0.28, a quick ratio of 2.61 and a current ratio of 2.61. The firm has a market cap of $1.66 billion, a P/E ratio of -20.62, a P/E/G ratio of 4.88 and a beta of 1.51. The firm has a 50-day simple moving average of $11.16 and a 200-day simple moving average of $13.81.

Certara (NASDAQ:CERT) last issued its quarterly earnings data on Tuesday, August 6th. The company reported $0.07 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.10 by ($0.03). Certara had a positive return on equity of 3.03% and a negative net margin of 21.64%. The firm had revenue of $93.31 million during the quarter, compared to analysts’ expectations of $96.01 million. During the same period in the previous year, the firm earned $0.10 EPS. The firm’s quarterly revenue was up 3.2% on a year-over-year basis. Equities analysts anticipate that Certara, Inc. will post 0.27 EPS for the current fiscal year.

Certara Company Profile

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.